Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110452141B reveals a green riboflavin-catalyzed route for diaryl sulfides, offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN108314642B reveals a green triethylamine-based route for 2-methylpyridines. Offers cost reduction and scalable pharma intermediate manufacturing without heavy metals.
Novel NHC-catalyzed route for trifluoromethyl homoisoflavones offers mild conditions and high yields, ensuring reliable supply chain stability.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Patent CN105294599B reveals a novel asymmetric synthesis for thiadiazine diuretics. Discover cost-effective catalytic methods and scalable supply chain solutions.
Discover the imidazole hydrochloride catalyzed synthesis of benzimidazoles. A robust method for high-purity pharmaceutical intermediates with significant cost advantages.
Patent CN109721590B details a novel cobalt-catalyzed method for C2 alpha acyloxy indole synthesis, offering cost reduction and improved regioselectivity for pharmaceutical intermediate manufacturing.
Patent CN114874139A details a green visible-light method for synthesizing dihydroisoquinoline intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN114605361B reveals a metal-free DABCO-catalyzed route for high-purity fluorinated butenolides. This method ensures cost efficiency and supply chain stability for pharmaceutical intermediates.
Novel iridium-catalyzed N-alkylation method for 2-(N-alkyl)aminopyrimidines using alcohols. High atom economy, water byproduct only. Ideal for pharma intermediates.
Novel patent CN116768904B discloses high-yield chiral synthesis. Offers cost reduction in pharmaceutical manufacturing and supply chain reliability for antitumor drug development.
Patent CN115385916B reveals high-yield chiral synthesis. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel chiral phosphoric acid catalysis enables high-yield synthesis of anticancer intermediates. Scalable, mild conditions offer supply chain stability and cost efficiency.
Patent CN113121462B reveals a metal-free route to 5-trifluoromethyl-1,2,3-triazoles. Enhances supply chain reliability and reduces costs in API manufacturing.
Novel synthesis method for axial chiral isopyrone-indole derivatives offering high enantioselectivity and cost-effective manufacturing for pharmaceutical applications.
Patent CN105111228A reveals enhanced chiral phosphoric acid synthesis. Offers superior enantioselectivity and industrial scalability for pharmaceutical manufacturing.
Patent CN102040594A introduces a recyclable chiral bisoxazoline ligand with imidazolium salts, offering superior enantioselectivity and stability for pharmaceutical intermediate manufacturing.
Novel metal-free synthesis of quinolyl-triazoles via oxidative cyclization. High yields up to 97%, scalable process for pharmaceutical intermediates.
Patent CN113087714B reveals a novel Rh(II)-catalyzed N-H insertion route for axial chiral indolocarbazoles, offering high enantioselectivity and scalable pharmaceutical intermediate manufacturing.